Related Experiment Videos
Functional complementation of xeroderma pigmentosum complementation group E by replication protein A in an in vitro
A Kazantsev1, D Mu, A F Nichols
1Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7260, USA.
Summary
Xeroderma pigmentosum (XP) patients with mild symptoms show DNA repair defects. Human replication/repair protein A (RPA) was found to correct this defect in vitro, though RPA genes were not mutated.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Xeroderma pigmentosum (XP) is a DNA repair disorder.
- XP complementation group E (XP-E) exhibits the mildest phenotype and highest residual DNA repair capacity.
- A subset of XP-E cell lines lack damaged DNA-binding protein (DDB) activity crucial for UV-induced DNA lesion recognition.
Purpose of the Study:
- To investigate the molecular basis of DNA repair defects in XP-E cell lines.
- To identify factors involved in the excision of UV-induced DNA damage.
- To determine the role of DDB and other proteins in XP-E cellular function.
Main Methods:
- Preparation and analysis of cell-free extracts from XP-E cell strains.
- Assessing DNA excision activity in vitro.
- Purification of correcting factors from HeLa cell extracts.
- Supplementation experiments with purified proteins, including recombinant human replication/repair protein A (RPA).
- Genetic analysis of RPA subunit genes in XP-E cell lines.
Main Results:
- XP-E cell extracts, regardless of DDB presence, showed severe defects in excising UV-induced DNA damage.
- Purified DDB did not restore, and even inhibited, excision activity.
- Purification revealed that the correcting activity is identical to human replication/repair protein A (RPA).
- Supplementation with recombinant RPA restored DNA excision activity in XP-E extracts.
- No mutations were identified in the RPA subunit genes in an XP-E (DDB-) cell line.
Conclusions:
- Human replication/repair protein A (RPA) functionally complements XP-E cell extracts in vitro, indicating its critical role in DNA repair.
- Despite the in vitro complementation, RPA is not genetically altered in XP-E patients, suggesting a complex regulatory or interactional defect.
- The findings highlight RPA's importance in nucleotide excision repair pathways relevant to XP pathogenesis.